<SEC-DOCUMENT>0001970051-25-000006.txt : 20250117
<SEC-HEADER>0001970051-25-000006.hdr.sgml : 20250117
<ACCEPTANCE-DATETIME>20250117144215
ACCESSION NUMBER:		0001970051-25-000006
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250117
DATE AS OF CHANGE:		20250117

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Adaptimmune Therapeutics PLC
		CENTRAL INDEX KEY:			0001621227
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-37368
		FILM NUMBER:		25538247

	BUSINESS ADDRESS:	
		STREET 1:		60 JUBILEE AVENUE
		STREET 2:		MILTON PARK
		CITY:			ABINGDON, OXFORDSHIRE
		STATE:			X0
		ZIP:			OX14 4RX
		BUSINESS PHONE:		44 1235 430000

	MAIL ADDRESS:	
		STREET 1:		60 JUBILEE AVENUE
		STREET 2:		MILTON PARK
		CITY:			ABINGDON, OXFORDSHIRE
		STATE:			X0
		ZIP:			OX14 4RX

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Adaptimmune Ltd
		DATE OF NAME CHANGE:	20141001

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Rawcliffe Adrian
		CENTRAL INDEX KEY:			0001555851
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		144

	MAIL ADDRESS:	
		STREET 1:		440 SOUTH BROAD STREET, UNIT 1906
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19146
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001555851</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001621227</issuerCik>
      <issuerName>Adaptimmune Therapeutics PLC</issuerName>
      <secFileNumber>001-37368</secFileNumber>
      <issuerAddress>
        <com:street1>60 JUBILEE AVENUE</com:street1>
        <com:street2>MILTON PARK</com:street2>
        <com:city>ABINGDON, OXFORDSHIRE</com:city>
        <com:stateOrCountry>X0</com:stateOrCountry>
        <com:zipCode>OX14 4RX</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>44 1235 430000</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Rawcliffe Adrian</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Chief Executive Officer</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>American Depositary Shares</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Maxim Group</name>
        <address>
          <com:street1>300 Park Ave 16th Floor</com:street1>
          <com:city>NEW YORK</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10022</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>30601</noOfUnitsSold>
      <aggregateMarketValue>17772.00</aggregateMarketValue>
      <noOfUnitsOutstanding>255880000</noOfUnitsOutstanding>
      <approxSaleDate>01/17/2025</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>American Depositary Shares</securitiesClassTitle>
      <acquiredDate>01/17/2025</acquiredDate>
      <natureOfAcquisitionTransaction>Sell to cover exercise (cashless)</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Adaptimmune Therapeutics plc</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>30601</amountOfSecuritiesAcquired>
      <paymentDate>01/17/2025</paymentDate>
      <natureOfPayment>COMPENSATION</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Adrian Rawcliffe</name>
        <address>
          <com:street1>60 JUBILEE AVENUE</com:street1>
          <com:street2>MILTON PARK</com:street2>
          <com:city>ABINGDON, OXFORDSHIRE</com:city>
          <com:stateOrCountry>X0</com:stateOrCountry>
          <com:zipCode>OX14 4RX</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>American Depositary Shares</securitiesClassTitle>
      <saleDate>01/13/2025</saleDate>
      <amountOfSecuritiesSold>30473</amountOfSecuritiesSold>
      <grossProceeds>17917.00</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Adrian Rawcliffe</name>
        <address>
          <com:street1>60 JUBILEE AVENUE, MILTON PARK</com:street1>
          <com:city>ABINGDON, OXFORDSHIRE</com:city>
          <com:stateOrCountry>X0</com:stateOrCountry>
          <com:zipCode>X0 OX14 4R</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>American Depositary Shares</securitiesClassTitle>
      <saleDate>01/15/2025</saleDate>
      <amountOfSecuritiesSold>29096</amountOfSecuritiesSold>
      <grossProceeds>16724.00</grossProceeds>
    </securitiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>01/17/2025</noticeDate>
      <signature>Adrian Rawcliffe</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
